Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis
Clinical trial NCT00667277 · TERMINATED
Trial details
- NCT number
- NCT00667277
- Sponsor
- Ronald Hoffman
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-03-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.